317 related articles for article (PubMed ID: 17893307)
1. Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes.
Hawkins C; Huang J; Jin N; Noskin GA; Zembower TR; Bolon M
Arch Intern Med; 2007 Sep; 167(17):1861-7. PubMed ID: 17893307
[TBL] [Abstract][Full Text] [Related]
2. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
Khatib R; Johnson LB; Sharma M; Fakih MG; Ganga R; Riederer K
Scand J Infect Dis; 2009; 41(1):4-9. PubMed ID: 18821135
[TBL] [Abstract][Full Text] [Related]
3. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.
Yoon YK; Kim JY; Park DW; Sohn JW; Kim MJ
J Antimicrob Chemother; 2010 May; 65(5):1015-8. PubMed ID: 20200036
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children.
Carrillo-Marquez MA; Hulten KG; Mason EO; Kaplan SL
Pediatr Infect Dis J; 2010 May; 29(5):410-4. PubMed ID: 20431380
[TBL] [Abstract][Full Text] [Related]
5. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Soriano A; Marco F; MartÃnez JA; Pisos E; Almela M; Dimova VP; Alamo D; Ortega M; Lopez J; Mensa J
Clin Infect Dis; 2008 Jan; 46(2):193-200. PubMed ID: 18171250
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.
Lin SH; Liao WH; Lai CC; Liao CH; Tan CK; Wang CY; Huang YT; Hsueh PR
J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
Sakoulas G; Brown J; Lamp KC; Friedrich LV; Lindfield KC
Clin Ther; 2009 Sep; 31(9):1936-45. PubMed ID: 19843483
[TBL] [Abstract][Full Text] [Related]
8. Predictors of high vancomycin MIC values among patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Lodise TP; Miller CD; Graves J; Evans A; Graffunder E; Helmecke M; Stellrecht K
J Antimicrob Chemother; 2008 Nov; 62(5):1138-41. PubMed ID: 18694905
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus bacteremia.
Jensen AG
Dan Med Bull; 2003 Nov; 50(4):423-38. PubMed ID: 14694855
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
Chang FY; Peacock JE; Musher DM; Triplett P; MacDonald BB; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
Medicine (Baltimore); 2003 Sep; 82(5):333-9. PubMed ID: 14530782
[TBL] [Abstract][Full Text] [Related]
11. Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia.
Khosrovaneh A; Riederer K; Saeed S; Tabriz MS; Shah AR; Hanna MM; Sharma M; Johnson LB; Fakih MG; Khatib R
Clin Infect Dis; 2004 May; 38(9):1328-30. PubMed ID: 15127350
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia.
Fowler VG; Justice A; Moore C; Benjamin DK; Woods CW; Campbell S; Reller LB; Corey GR; Day NP; Peacock SJ
Clin Infect Dis; 2005 Mar; 40(5):695-703. PubMed ID: 15714415
[TBL] [Abstract][Full Text] [Related]
13. Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia.
Neuner EA; Casabar E; Reichley R; McKinnon PS
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):228-33. PubMed ID: 20542203
[TBL] [Abstract][Full Text] [Related]
14. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
[TBL] [Abstract][Full Text] [Related]
15. [Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis].
Falcone M; Carfagna P; Cassone M; Pistella E; Pavoni G; Nofroni I; Serra P; Venditti M
Ann Ital Med Int; 2002; 17(3):166-72. PubMed ID: 12402664
[TBL] [Abstract][Full Text] [Related]
16. Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome.
Senthilkumar A; Kumar S; Sheagren JN
Clin Infect Dis; 2001 Oct; 33(8):1412-6. PubMed ID: 11565083
[TBL] [Abstract][Full Text] [Related]
17. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.
Kullar R; Davis SL; Levine DP; Rybak MJ
Clin Infect Dis; 2011 Apr; 52(8):975-81. PubMed ID: 21460309
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of Staphylococcus aureus bacteraemia.
Mitchell DH; Howden BP
Intern Med J; 2005 Dec; 35 Suppl 2():S17-24. PubMed ID: 16271058
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus bloodstream infections in older adults: clinical outcomes and risk factors for in-hospital mortality.
Big C; Malani PN
J Am Geriatr Soc; 2010 Feb; 58(2):300-5. PubMed ID: 20070420
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic-resistant bloodstream infections in hospitalized patients: specific risk factors in a high-risk population?
von Baum H; Ober JF; Wendt C; Wenzel RP; Edmond MB
Infection; 2005 Oct; 33(5-6):320-6. PubMed ID: 16258861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
